文献速递自身炎症与 IgG4 相关病

IgG4相关疾病的临床表型反映不同的预后结局

Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究基于潜在类别分析(LCA)已识别的四种IgG4相关疾病(IgG4-RD)临床表型,由四位专家对40例验证队列进行临床分型,与LCA分型强一致(κ=0.841,P<0.0005)。在另外139例患者中分析发现,不同表型在血清IgG4/IgE水平、IgG4-RD应答指数(RI)、累积糖皮质激素剂量及糖尿病发生率等方面存在差异,但疾病复发、复发时间及利妥昔单抗使用频率无差异。结论认为IgG4-RD临床表型反映了流行病学特征和预后结局的差异。

要点

  • 临床专家判断可重现LCA分型,一致性强(κ=0.841,P<0.0005)。
  • 组1起病时血清IgG4和IgE水平最高,组2和组4的IgG4-RD RI分别最低和最高。
  • 随访2年组3累积糖皮质激素剂量最高,组1和组4糖尿病发生率更高。

核心结论

  • IgG4-RD的临床表型反映了流行病学特征和预后结局的差异。

研究设计与样本

  • 研究纳入179例患者,其中40例由四位IgG4-RD专家根据已发表的LCA衍生表型进行临床分型验证,另139例用于表型间变量比较。

主要发现

  • 临床判断与LCA分型强一致(κ=0.841,P<0.0005)。
  • 起病时组1血清IgG4和IgE水平最高,组2和组4的IgG4-RD RI分别最低和最高。
  • 随访2年组3累积糖皮质激素剂量最高,组1和组4糖尿病发生率更高。
  • 四组间疾病复发、复发时间及利妥昔单抗输注频率无差异。

关键数值与推荐

  • 临床判断重现LCA分型的κ值为0.841(P<0.0005)。

临床怎么用

  • 临床可依据LCA衍生的四种表型对IgG4-RD患者进行分型,以识别不同预后风险并个体化管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Four clinical phenotypes of IgG4-related disease (IgG4-RD) have been recently identified by latent class analysis (LCA): pancreato-biliary (group 1); retroperitoneum/aortitis (group 2); head and neck limited (group 3); and Mikulicz/systemic (group 4). The reproducibility of this classification in clinical practice and its relevance for patient management, however, remain unknown. METHODS: The study included 179 patients. Four IgG4-RD experts were asked to classify a validation cohort of 40 patients according to published LCA-derived phenotypes based on clinical judgement. Agreement between LCA and clinical clustering was calculated. To assess differences among disease phenotypes, the following variables were recorded on an additional 139 patients: serum IgG4 and IgE; inflammatory markers; eosinophils; plasmablasts; IgG4-RD responder index (RI); history of atopy, diabetes, osteoporosis, relapses and malignancy; cumulative dose of glucocorticoids; and use of rituximab. RESULTS: Clinical judgement replicated LCA classification with strong agreement among IgG4-RD experts (κ = 0.841, P < 0.0005). At disease onset, group 1 showed the highest levels of serum IgG4 and IgE. Groups 2 and 4 had the lowest and highest IgG4-RD RI, respectively. At 2 years' follow-up, group 3 received the highest cumulative dose of glucocorticoids, but higher incidences of diabetes mellitus were observed in groups 1 and 4, consistent with the higher likelihood of pancreatic involvement in groups 1 and 4. No difference among the four groups was observed in terms of disease recurrence, time to relapse and frequency of rituximab infusion. CONCLUSION: Clinical phenotypes of IgG4-RD reflect differences in epidemiological features and prognostic outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lanzillotta M, Campochiaro C, Mancuso G, et al. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes. Rheumatology (Oxford). 2020. PMID: 32591828. doi:10.1093/rheumatology/keaa221

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。